ADEMPAS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
ADEMPAS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Commercialized
Register Number
13907013IP
Prescription Type
Uso Hospitalario
Authorization Date
Mar 9, 2023
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number13907013IP
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
RIOCIGUATActive
Quantity: 2,5 mg
Name: RIOCIGUAT
ATC CLASSIFICATION (3)
C02K
C02KX
C02KX05